EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Arcutis Biotherapeutics, Inc. (ARQT) had EBIT Margin of -8.62% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$105.40M |
|
$-11.29M |
|
$9.78M |
|
$95.61M |
|
$114.49M |
|
$-9.09M |
|
$-2.11M |
|
$-11.20M |
|
$-11.20M |
|
$-11.29M |
|
$-11.29M |
|
$-11.29M |
|
$-11.29M |
|
$-9.09M |
|
$-8.71M |
|
129.37M |
|
129.37M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$438.06M |
|
$1.04M |
|
$21.95M |
|
$460.00M |
|
$163.20M |
|
$101.47M |
|
$107.15M |
|
$270.36M |
|
$189.65M |
|
$175.40M |
|
$189.65M |
|
125.04M |
|
| Cash Flow Statement Financials | |
$2.24M |
|
$-11.33M |
|
$1.07M |
|
$43.22M |
|
$35.07M |
|
$-8.14M |
|
$10.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.68 |
|
-- |
|
-- |
|
0.35 |
|
0.58 |
|
90.72% |
|
-8.62% |
|
|
EBIT Margin |
-8.62% |
-- |
|
-10.63% |
|
-10.72% |
|
$2.24M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.26 |
|
0.73 |
|
123.28 |
|
-5.96% |
|
-6.44% |
|
-2.46% |
|
-3.88% |
|
$1.52 |
|
$0.02 |
|
$0.02 |
|